Therapeutic areas graphic
760+ Sites
Around the world

Working to meet sponsors' needs in IBD

As the need for clinical trials in gastroenterology grows, CRO collaboration matters more than ever.

Clinical trials in Crohn’s disease and ulcerative colitis are at the core of PSI’s expertise.
We're dedicated to delivering trials on time and on budget.

Clinical trials in Crohn’s disease and ulcerative colitis are at the core of PSI’s expertise. IBD represents a dedicated therapeutic area at PSI supported by experienced therapeutic leads and operational teams. In the recent years, we have been managing global clinical trials in a variety of drug types. PSI has built an extensive network of IBD sites across Europe, North America, Latin America, South Africa, Russia, India, South Korea, Taiwan and Australia.

Our dedication to on-time trial delivery is at the core of our commitment to our IBD sponsors.

Meet the global clinical research organization ranked No. 1.

“One of the most seamless partnerships between a sponsor and a CRO that I have ever seen.” VP Global Clinical Operations

The PSI Advantage

Ranked #1 Global CRO by Investigators Worldwide

Ranked #1 Global CRO by Investigators
Worldwide. CenterWatch 2015-2017

Therapeutic areas

Other therapeutic areas of expertise